BIOMAT Database Logo BIOMAT Database Logo

Salvage high dose rate brachytherapy after primary external beam irradiation in localized prostate cancer: a case report. 2009

Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
Division of Radiotherapy, European Institute of Oncology, Milan, Italy.

No standard treatment exists for locally relapsed prostate cancer after primary external beam radiotherapy with no evidence of distant metastases. Radical prostatectomy, brachytherapy, cryotherapy and high-intensity focused ultrasound are currently used as local salvage treatments. Data on the safety and effectiveness of high dose rate (HDR) brachytherapy in this scenario are limited. We report on a patient who has no evidence of disease and no late urinary or gastrointestinal toxicity 33 months after receiving HDR treatment for recurrent prostate cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D016879 Salvage Therapy A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases. Salvage Treatment,Therapy, Salvage,Salvage Therapies,Salvage Treatments,Therapies, Salvage,Treatment, Salvage,Treatments, Salvage

Related Publications

Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
Salvage brachytherapy after external-beam irradiation for prostate cancer.
February 2004, Oncology (Williston Park, N.Y.),
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
Necrotizing fasciitis after high-dose rate brachytherapy and external beam radiation for prostate cancer: a case report.
November 2017, BMC urology,
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer.
July 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
Salvage prostate brachytherapy for localized prostate cancer failure after external beam radiation therapy.
January 2008, Brachytherapy,
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
March 2021, Scientific reports,
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
[High-dose rate iridium-192 brachytherapy combined with external beam radiotherapy for localized prostate cancer].
July 2001, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
[High-dose-rate brachytherapy with external beam radiotherapy for localized or locally advanced prostate cancer].
April 2010, Fukuoka igaku zasshi = Hukuoka acta medica,
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.
March 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer.
November 1996, British journal of cancer,
Luigi De Cicco, and Andrea Vavassori, and Federica Cattani, and Barbara A Jereczek-Fossa, and Roberto Orecchia
Salvage low-dose-rate (125)I partial prostate brachytherapy after dose-escalated external beam radiotherapy.
October 2014, Journal of contemporary brachytherapy,
Copied contents to your clipboard!